Evelo Biosciences *
Evelo Biosciences was a Flagship Pioneering-founded, GV-backed microbiome biotechnology company in Cambridge, Massachusetts, developing orally delivered investigational medicines acting on the small intestinal axis. Following clinical failures of its lead candidates EDP1815 and EDP2939, the company announced dissolution in November 2023 and has been wound down. It is retained in the API Evangelist network as a dissolved life-sciences portfolio record: the evelobio.com domain now serves only a parked catch-all error page and the company publishes no developer portal, documentation, or API surface of any kind.
Evelo Biosciences * is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Microbiome, and Pharmaceuticals.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API